SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
出版年份 2021 全文链接
标题
SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
作者
关键词
-
出版物
Biomolecules
Volume 11, Issue 4, Pages 607
出版商
MDPI AG
发表日期
2021-04-20
DOI
10.3390/biom11040607
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Culture of SARS-CoV-2 in a panel of laboratory cell lines, permissivity, and differences in growth profile
- (2021) Nathalie Wurtz et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
- (2021) Hongbo Liu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Pseudo-Dipeptide Bearing α,α-Difluoromethyl Ketone Moiety as Electrophilic Warhead with Activity against Coronaviruses
- (2021) Andrea Citarella et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
- (2021) Luca Pinzi et al. Frontiers in Pharmacology
- X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
- (2021) Sebastian Günther et al. SCIENCE
- Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19
- (2021) Brian T. Garibaldi et al. JAMA Network Open
- Profiling of flaviviral NS2B-NS3 protease specificity provides a structural basis for the development of selective chemical tools that differentiate Dengue from Zika and West Nile viruses
- (2020) Wioletta Rut et al. ANTIVIRAL RESEARCH
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV
- (2020) Jared S. Morse et al. CHEMBIOCHEM
- Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs
- (2020) Hui Luo et al. Chinese Journal of Integrative Medicine
- α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
- (2020) Linlin Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baicalin and its aglycone: a novel approach for treatment of metabolic disorders
- (2020) Penghua Fang et al. Pharmacological Reports
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms
- (2020) Bodee Nutho et al. BIOCHEMISTRY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design
- (2020) Maria Bzówka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Coronavirus Disease 2019 (COVID‐19): What we know?
- (2020) Feng He et al. JOURNAL OF MEDICAL VIROLOGY
- In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2’s Main Protease
- (2020) Tien Huynh et al. Journal of Physical Chemistry Letters
- Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity
- (2020) Yuanmei Zhu et al. JOURNAL OF VIROLOGY
- Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
- (2020) Davide Gentile et al. Marine Drugs
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
- (2020) Zhenming Jin et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Commentary: Origin and evolution of pathogenic coronaviruses
- (2020) Shun Adachi et al. Frontiers in Immunology
- Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
- (2020) Xiaoyan Liu et al. Acta Pharmaceutica Sinica B
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
- (2020) Muhammad Tahir ul Qamar et al. Journal of Pharmaceutical Analysis
- Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)
- (2020) Muhammad Shahid Nadeem et al. Pathogens
- Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
- (2020) Hai-xia Su et al. ACTA PHARMACOLOGICA SINICA
- Atazanavir, alone or in combination with ritonavir, inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production
- (2020) Natalia Fintelman-Rodrigues et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Peptidyl Acyloxymethyl Ketones as Activity‐Based Probes for the Main Protease of SARS‐CoV‐2
- (2020) Merel A. T. van de Plassche et al. CHEMBIOCHEM
- Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
- (2020) Shiyong Fan et al. Future Medicinal Chemistry
- Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics
- (2020) Sonya VanPatten et al. Future Medicinal Chemistry
- SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
- (2020) Natacha S. Ogando et al. JOURNAL OF GENERAL VIROLOGY
- Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells
- (2020) Na Zhu et al. Nature Communications
- In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
- (2020) Franck Touret et al. Scientific Reports
- Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
- (2020) Andrea J. Pruijssers et al. Cell Reports
- Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry
- (2020) Zachary A. Gurard-Levin et al. ANTIVIRAL RESEARCH
- Structure-Based Design of Novel Peptidomimetics Targeting the SARS-CoV-2 Spike Protein
- (2020) Manikandan Alagumuthu et al. Cellular and Molecular Bioengineering
- Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay
- (2020) Eleni Pitsillou et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine
- (2020) Davide Gentile et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CLpro Reporter Assay
- (2020) Heather M. Froggatt et al. JOURNAL OF VIROLOGY
- Peptidyl Fluoromethyl Ketones and Their Applications in Medicinal Chemistry
- (2020) Andrea Citarella et al. MOLECULES
- Chemoselective Homologation–Deoxygenation Strategy Enabling the Direct Conversion of Carbonyls into (n+1)-Halomethyl-Alkanes
- (2020) Margherita Miele et al. ORGANIC LETTERS
- Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
- (2020) Zhe Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection
- (2020) Shin-ichiro Hattori et al. mBio
- Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2020) Wayne Vuong et al. Nature Communications
- A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**
- (2020) Kai S. Yang et al. ChemMedChem
- Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
- (2020) Mohamed Mahdi et al. Virology Journal
- Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection
- (2020) Prashant Khare et al. VIRUS RESEARCH
- Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
- (2020) Giovanni Bolcato et al. Scientific Reports
- Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode
- (2020) Jian Li et al. Science Bulletin
- Validating Enterovirus D68-2Apro as an Antiviral Drug Target and the Discovery of Telaprevir as a Potent D68-2Apro Inhibitor
- (2019) Rami Musharrafieh et al. JOURNAL OF VIROLOGY
- Inhibition of SARS-CoV 3CL protease by flavonoids
- (2019) Seri Jo et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Direct and Chemoselective Synthesis of Tertiary Difluoroketones via Weinreb Amide Homologation with a CHF2-Carbene Equivalent
- (2019) Margherita Miele et al. ORGANIC LETTERS
- The Comparative Study of the Therapeutic Effects and Mechanism of Baicalin, Baicalein, and Their Combination on Ulcerative Colitis Rat
- (2019) Shuai Liang et al. Frontiers in Pharmacology
- Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders
- (2017) Biswanath Dinda et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis
- (2017) Niels C Pedersen et al. JOURNAL OF FELINE MEDICINE AND SURGERY
- Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Jonathan Kil et al. LANCET
- Proteases and protease inhibitors in infectious diseases
- (2017) Ayodeji A. Agbowuro et al. MEDICINAL RESEARCH REVIEWS
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
- (2016) Thanigaimalai Pillaiyar et al. JOURNAL OF MEDICINAL CHEMISTRY
- SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
- (2016) Tomonari Muramatsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing
- (2016) Charles Masaki et al. PSYCHOPHARMACOLOGY
- Broad-Spectrum Inhibitors against 3C-Like Proteases of Feline Coronaviruses and Feline Caliciviruses
- (2015) Yunjeong Kim et al. JOURNAL OF VIROLOGY
- Critical Assessment of the Important Residues Involved in the Dimerization and Catalysis of MERS Coronavirus Main Protease
- (2015) Bo-Lin Ho et al. PLoS One
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
- (2014) Rolf Hilgenfeld FEBS Journal
- Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
- (2014) Jean Kaoru Millet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?
- (2012) Jasper F.W. Chan et al. JOURNAL OF INFECTION
- Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
- (2011) Lili Zhu et al. ANTIVIRAL RESEARCH
- Profiling of Substrate Specificities of 3C-Like Proteases from Group 1, 2a, 2b, and 3 Coronaviruses
- (2011) Chi-Pang Chuck et al. PLoS One
- Two adjacent mutations on the dimer interface of SARS coronavirus 3C-like protease cause different conformational changes in crystal structure
- (2009) Tiancen Hu et al. VIROLOGY
- Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
- (2008) F. George Njoroge et al. ACCOUNTS OF CHEMICAL RESEARCH
- Activity-Based Protein Profiling: From Enzyme Chemistry to Proteomic Chemistry
- (2008) Benjamin F. Cravatt et al. Annual Review of Biochemistry
- Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
- (2008) Yi-Ming Shao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Peptidomimetics, a synthetic tool of drug discovery
- (2008) Josef Vagner et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Update on viral hepatitis: 2007
- (2008) Bulent Degertekin et al. CURRENT OPINION IN GASTROENTEROLOGY
- Without Its N-Finger, the Main Protease of Severe Acute Respiratory Syndrome Coronavirus Can Form a Novel Dimer through Its C-Terminal Domain
- (2008) N. Zhong et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now